Contents

, was of variable quality, and there were many interventions of interest where the evidence base was limited or nonexistent. While women experiencing menopausal symptoms after breast cancer treatment are the population targeted by the guidelines, it was recognised that clinical trial evidence from a general female menopausal population is generalisable to a breast cancer population. ................
................